NASDAQ · PPH
VanEck Pharmaceutical ETF
$119.33+$2.41 (+2.06%)
VanEck Pharmaceutical ETF’s quoted price sits in the upper half of its reported 52-week range, 1.27% below the high.
Loading market information…
AMEX · SGDM · USD
Stock price, dividends
Quote as of Oct 30, 2026, 08:00 PM UTC. Cached market data; not a live quote.
One-year closing-price history · USD. Historical prices are not a forecast.
Sprott Gold Miners ETF’s quoted price sits in the lower half of its reported 52-week range, 32.79% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
THE INCOME SIDE
Sprott Gold Miners ETF’s forward annual dividend is $0.73 per share, paid annual. The forward yield is 1.12% at the quoted price. Future payments can change.
Historical amounts are adjusted for stock splits. Understand ex-dividend and payment dates →
THE COMPANY BEHIND THE TICKER
The Sprott Gold Miners ETF (SGDM) endeavors to replicate the investment performance of its underlying benchmark index. This index specifically targets gold-producing companies situated in the United States and Canada, provided their common stock or American Depositary Receipts (ADRs) are traded on the Toronto Stock Exchange, the New York Stock Exchange, or NASDAQ. Typically, the fund commits a substantial portion—at least 90% of its net assets—to the very securities that compose this index. It is important to note that this fund maintains a non-diversified status.
Latest available per-share figures in USD. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 31, 2026, 11:35 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
Completed calendar years and any current-year payments shown separately. Current-year totals are incomplete until all payments are made.
See annual income at the current dividend rate.
Assumes the annual dividend stays unchanged. Payments follow the company’s schedule. Excludes taxes, fees and currency changes.
KEEP COMPARING
$119.33+$2.41 (+2.06%)
VanEck Pharmaceutical ETF’s quoted price sits in the upper half of its reported 52-week range, 1.27% below the high.
$54.17-$0.72 (-1.31%)
Franklin FTSE Canada ETF’s quoted price sits in the upper half of its reported 52-week range, 3.2% below the high.
$246.64-$1.82 (-0.73%)
State Street SPDR S&P 1500 Value Tilt ETF’s quoted price sits in the upper half of its reported 52-week range, 1.73% below the high.
$51.89-$0.18 (-0.35%)
ALPS Equal Sector Weight ETF’s quoted price sits in the upper half of its reported 52-week range, 1.46% below the high.
$68.27-$0.73 (-1.06%)
Hartford Multifactor US Equity ETF’s quoted price sits in the upper half of its reported 52-week range, 1.49% below the high.
$60.63-$0.89 (-1.44%)
Goldman Sachs MarketBeta Total International Equity ETF’s quoted price sits in the upper half of its reported 52-week range, 7.46% below the high.
$101.00-$0.55 (-0.54%)
VictoryShares US 500 Volatility Wtd ETF’s quoted price sits in the upper half of its reported 52-week range, 2.05% below the high.
$29.81-$0.03 (-0.1%)
Harbor International Compounders ETF (OSEA)’s quoted price sits in the upper half of its reported 52-week range, 5.66% below the high.
